Home > Press > NineSigma Adds Key Program Management Team Members to Oversee Increasing Project Demand
Abstract:
Irina Shiyanovskaya, Stephanie Orellana, and Ryan Hartschuh Bring Ph.D. Level Expertise in Industries Including Advanced Materials, Biotechnology, Pharmaceuticals and Nanotechnology
NineSigma Adds Key Program Management Team Members to Oversee Increasing Project Demand
Cleveland, OH | Posted on December 4th, 2007
NineSigma, a leading provider of open innovation solutions, today announced the expansion of its program management team, including Irina Shiyanovskaya, Ph.D., Stephanie Orellana, Ph.D. and Ryan Hartschuh, Ph.D. As the result of an increase in demand and diversity of open innovation projects from Global 1000 companies, NineSigma added strategic program management resources to support the growing client demand.
Dr. Shiyanovskaya, a physicist and materials scientist, joins NineSigma as a Program Manager with industrial and academic expertise in fields including advanced materials, polymers/liquid crystals, bioengineering, nanotechnology, organic electronics and photonics. Prior to joining NineSigma, Dr. Shiyanovskaya was a Principal Scientist at Kent Displays Inc., where she developed flexible display technology. Dr. Shiyanovskaya, who serves as an Adjunct Professor at Case Western, earned an MS in Physics and Materials Science from Kiev National University and a Ph.D. in Physics and Mathematics from the Institute of Physics, National Academy of Sciences in Ukraine.
Dr. Orellana brings significant experience in education, biomedical research, project development, and management, and joins NineSigma as a Program Manager responsible for designing, consulting and executing client projects. Prior to joining NineSigma, Dr. Orellana served as faculty at the University of Washington and Case Western Reserve University, where she was responsible for the overall deployment and implementation of research projects specifically related to understanding the cellular mechanisms of human disease. Dr. Orellana received a BS in Biology from MIT and earned her Ph.D. in Physiology and Pharmacology from the University of California at San Diego.
Dr. Ryan Hartschuh, with expertise in optics, polymer science, and nanotechnology, joins NineSigma as an Assistant Program Manager. Prior to NineSigma, Dr. Hartschuh helped to develop a new spectroscopy technique capable of topographic and spectroscopic imaging with spatial resolution unprecedented for optical microscopy. Dr. Hartschuh received a BA in Physics from The College of Wooster and his Ph.D. in Polymer Science in 2007 from the University of Akron.
"A key component to NineSigma's unique open innovation approach is the talent pool of Ph.D. level program managers serving a diverse customer base," said Paul Stiros, CEO of NineSigma. "These strategic additions to our program management team further exemplify the growth we continue to see in open innovation projects from diverse industries and disciplines."
####
About NineSigma
NineSigma partners with Global 1000 companies to transform their innovation capabilities by connecting them with the very best innovators from around the world. NineSigma's proprietary process for Open Innovation enables companies to dramatically improve speed to market while lowering product development costs. NineSigma's open network of innovators is the largest of its kind and spans industries, geographies, and technical disciplines. Companies such as P&G, GlaxoSmithKline, DuPont, Kraft, General Mills and Unilever engage NineSigma to build new innovation capabilities that leverage research and innovation globally to deliver greater value to their customers.
For more information, please click here
Contacts:
Media Contact:
Jordan Lubowitz
781-487-4677
Copyright © Marketwire
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Appointments/Promotions/New hires/Resignations/Deaths
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
SEMATECH Names William R. Rozich Chairman of the Board June 13th, 2013
David Neuschuler Joins RASIRC to Manage Engineering June 3rd, 2013
Asylum Research Announces Ben Ohler as AFM Business Manager May 29th, 2013